Your browser doesn't support javascript.
loading
Prospective Longitudinal Assessment of Quality of Life and Activities of Daily Living as Patient-Reported Outcome Measures in Recurrent/Progressive Glioma Treated with High-dose Salvage Re-irradiation.
Maitre, P; Gupta, T; Maitre, M; Goda, J; Krishnatry, R; Chatterjee, A; Sridhar, E; Sahay, A; Mokal, S; Moiyadi, A; Shetty, P; Patil, V; Jalali, R.
Afiliación
  • Maitre P; Department of Radiation Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Gupta T; Department of Radiation Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India. Electronic address: tejpalgupta@rediffmail.com.
  • Maitre M; Department of Radiation Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Goda J; Department of Radiation Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Krishnatry R; Department of Radiation Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Chatterjee A; Department of Radiation Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Sridhar E; Department of Pathology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Sahay A; Department of Pathology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Mokal S; Clinical Research Secretariat, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Moiyadi A; Division of Neuro-surgical Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Shetty P; Division of Neuro-surgical Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Patil V; Department of Medical Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Jalali R; Department of Radiation Oncology, Neuro-Oncology Disease Management Group, (ACTREC/TMH), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
Clin Oncol (R Coll Radiol) ; 33(3): e155-e165, 2021 03.
Article en En | MEDLINE | ID: mdl-32917486
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Actividades Cotidianas / Reirradiación / Glioma Tipo de estudio: Guideline / Observational_studies Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Actividades Cotidianas / Reirradiación / Glioma Tipo de estudio: Guideline / Observational_studies Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article